JNJ logo

Johnson & Johnson (JNJ) EBITDA

annual EBITDA:

$21.25B-$2.07B(-8.88%)
December 29, 2024

Summary

  • As of today (April 17, 2025), JNJ annual EBITDA is $21.25 billion, with the most recent change of -$2.07 billion (-8.88%) on December 29, 2024.
  • During the last 3 years, JNJ annual EBITDA has fallen by -$5.50 billion (-20.57%).
  • JNJ annual EBITDA is now -20.57% below its all-time high of $26.75 billion, reached on December 31, 2021.

Performance

JNJ EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJNJincome statement metrics

quarterly EBITDA:

$3.64B-$1.74B(-32.29%)
December 29, 2024

Summary

  • As of today (April 17, 2025), JNJ quarterly EBITDA is $3.64 billion, with the most recent change of -$1.74 billion (-32.29%) on December 29, 2024.
  • Over the past year, JNJ quarterly EBITDA has dropped by -$1.74 billion (-32.29%).
  • JNJ quarterly EBITDA is now -61.21% below its all-time high of $9.39 billion, reached on March 1, 2021.

Performance

JNJ quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJNJincome statement metrics

TTM EBITDA:

$22.50B-$3.18B(-12.38%)
December 29, 2024

Summary

  • As of today (April 17, 2025), JNJ TTM EBITDA is $22.50 billion, with the most recent change of -$3.18 billion (-12.38%) on December 29, 2024.
  • Over the past year, JNJ TTM EBITDA has dropped by -$3.18 billion (-12.38%).
  • JNJ TTM EBITDA is now -20.20% below its all-time high of $28.20 billion, reached on March 31, 2024.

Performance

JNJ TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJNJincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

JNJ EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.9%-32.3%-12.4%
3 y3 years-20.6%+352.3%+6.5%
5 y5 years-13.8%+352.3%+6.5%

JNJ EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-20.6%at low-57.0%+352.3%-20.2%+6.5%
5 y5-year-20.6%at low-61.2%+352.3%-20.2%+6.5%
alltimeall time-20.6%+2086.6%-61.2%+167.5%-20.2%+1286.8%

Johnson & Johnson EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$21.25B(-8.9%)
$3.64B(-32.3%)
$22.50B(-12.4%)
Sep 2024
-
$5.38B(-31.1%)
$25.68B(-6.8%)
Jun 2024
-
$7.80B(+37.2%)
$27.54B(-2.3%)
Mar 2024
-
$5.68B(-16.7%)
$28.20B(+20.9%)
Dec 2023
$23.32B(-12.3%)
$6.82B(-5.8%)
$23.32B(+4.6%)
Sep 2023
-
$7.24B(-14.4%)
$22.29B(+1.5%)
Jun 2023
-
$8.46B(+950.6%)
$21.96B(+4.0%)
Mar 2023
-
$805.00M(-86.1%)
$21.12B(-24.4%)
Dec 2022
$26.61B(-0.5%)
$5.79B(-16.2%)
$27.96B(+10.5%)
Sep 2022
-
$6.91B(-9.4%)
$25.31B(+5.1%)
Jun 2022
-
$7.62B(-0.2%)
$24.09B(-3.7%)
Mar 2022
-
$7.64B(+143.3%)
$25.01B(-6.5%)
Dec 2021
$26.75B(+11.8%)
$3.14B(-44.7%)
$26.75B(-2.0%)
Sep 2021
-
$5.68B(-33.5%)
$27.28B(-2.1%)
Jun 2021
-
$8.54B(-9.0%)
$27.86B(+11.3%)
Mar 2021
-
$9.39B(+155.5%)
$25.03B(+4.6%)
Dec 2020
$23.93B(-2.9%)
-
-
Dec 2020
-
$3.67B(-41.3%)
$23.93B(-9.3%)
Sep 2020
-
$6.26B(+9.7%)
$26.37B(+12.1%)
Jun 2020
-
$5.71B(-31.0%)
$23.53B(-11.7%)
Mar 2020
-
$8.28B(+35.3%)
$26.65B(+8.1%)
Dec 2019
$24.66B(-4.9%)
$6.12B(+78.8%)
$24.66B(+4.3%)
Sep 2019
-
$3.42B(-61.2%)
$23.64B(-11.2%)
Jun 2019
-
$8.83B(+40.5%)
$26.62B(+7.6%)
Mar 2019
-
$6.29B(+23.1%)
$24.73B(-4.6%)
Dec 2018
$25.93B(+6.9%)
$5.11B(-20.2%)
$25.93B(+1.6%)
Sep 2018
-
$6.40B(-7.9%)
$25.53B(-1.3%)
Jun 2018
-
$6.94B(-7.3%)
$25.86B(+3.3%)
Mar 2018
-
$7.49B(+59.2%)
$25.04B(+3.3%)
Dec 2017
$24.25B(-0.1%)
$4.70B(-30.1%)
$24.25B(-3.4%)
Sep 2017
-
$6.73B(+9.9%)
$25.11B(+1.4%)
Jun 2017
-
$6.13B(-8.5%)
$24.76B(+0.5%)
Mar 2017
-
$6.69B(+20.3%)
$24.63B(+1.4%)
Dec 2016
$24.28B(+3.4%)
$5.56B(-12.8%)
$24.28B(+2.6%)
Sep 2016
-
$6.38B(+6.5%)
$23.67B(+5.4%)
Jun 2016
-
$5.99B(-5.5%)
$22.46B(-3.3%)
Mar 2016
-
$6.34B(+28.2%)
$23.23B(-1.1%)
Dec 2015
$23.49B(-6.0%)
$4.95B(-4.3%)
$23.49B(+5.0%)
Sep 2015
-
$5.17B(-23.5%)
$22.38B(-10.8%)
Jun 2015
-
$6.76B(+2.3%)
$25.08B(+0.2%)
Mar 2015
-
$6.61B(+72.4%)
$25.03B(+0.1%)
Dec 2014
$24.99B(+24.6%)
$3.83B(-51.4%)
$24.99B(-0.6%)
Sep 2014
-
$7.88B(+17.5%)
$25.14B(+14.2%)
Jun 2014
-
$6.71B(+2.0%)
$22.01B(+3.8%)
Mar 2014
-
$6.57B(+64.9%)
$21.21B(+5.7%)
Dec 2013
$20.06B(+11.6%)
$3.99B(-16.0%)
$20.06B(-1.3%)
Sep 2013
-
$4.75B(-19.5%)
$20.31B(+0.1%)
Jun 2013
-
$5.90B(+8.8%)
$20.30B(+16.5%)
Mar 2013
-
$5.42B(+27.8%)
$17.43B(-3.0%)
Dec 2012
$17.97B(+11.7%)
$4.24B(-10.4%)
$17.97B(+19.2%)
Sep 2012
-
$4.74B(+56.3%)
$15.07B(-1.9%)
Jun 2012
-
$3.03B(-49.2%)
$15.37B(-7.8%)
Mar 2012
-
$5.96B(+343.8%)
$16.66B(+3.6%)
Dec 2011
$16.09B(-20.9%)
$1.34B(-73.3%)
$16.09B(-10.0%)
Sep 2011
-
$5.03B(+16.2%)
$17.88B(-0.1%)
Jun 2011
-
$4.33B(-19.7%)
$17.91B(-3.8%)
Mar 2011
-
$5.39B(+71.9%)
$18.61B(-8.5%)
Dec 2010
$20.34B(+7.2%)
$3.13B(-37.9%)
$20.34B(-1.5%)
Sep 2010
-
$5.05B(+0.4%)
$20.65B(-0.0%)
Jun 2010
-
$5.03B(-29.3%)
$20.66B(-0.1%)
Mar 2010
-
$7.12B(+107.0%)
$20.68B(+8.9%)
Dec 2009
$18.98B(-6.0%)
$3.44B(-32.0%)
$18.98B(-4.5%)
Sep 2009
-
$5.06B(+0.2%)
$19.88B(-0.6%)
Jun 2009
-
$5.05B(-6.9%)
$20.00B(-0.6%)
Mar 2009
-
$5.42B(+24.9%)
$20.11B(-0.4%)
Dec 2008
$20.20B(+23.5%)
$4.34B(-16.2%)
$20.20B(+10.5%)
Sep 2008
-
$5.18B(+0.3%)
$18.27B(+3.5%)
Jun 2008
-
$5.16B(-6.3%)
$17.65B(+3.5%)
Mar 2008
-
$5.51B(+128.2%)
$17.05B(+4.2%)
Dec 2007
$16.36B(+3.0%)
$2.42B(-47.0%)
$16.36B(-6.2%)
Sep 2007
-
$4.56B(-0.0%)
$17.45B(+2.3%)
Jun 2007
-
$4.56B(-5.4%)
$17.05B(+3.8%)
Mar 2007
-
$4.82B(+37.6%)
$16.43B(+3.4%)
Dec 2006
$15.89B(+6.4%)
$3.50B(-15.9%)
$15.89B(+4.5%)
Sep 2006
-
$4.17B(+5.7%)
$15.20B(+2.6%)
Jun 2006
-
$3.94B(-7.8%)
$14.81B(-0.3%)
Mar 2006
-
$4.27B(+51.6%)
$14.86B(-0.4%)
Dec 2005
$14.92B(+3.1%)
$2.82B(-25.4%)
$14.92B(+0.3%)
Sep 2005
-
$3.78B(-5.2%)
$14.88B(-0.1%)
Jun 2005
-
$3.98B(-8.2%)
$14.89B(+0.2%)
Mar 2005
-
$4.34B(+56.4%)
$14.86B(+2.6%)
Dec 2004
$14.48B
$2.77B(-26.8%)
$14.48B(+0.3%)
DateAnnualQuarterlyTTM
Sep 2004
-
$3.79B(-4.1%)
$14.43B(+3.2%)
Jun 2004
-
$3.95B(-0.1%)
$13.99B(+4.8%)
Mar 2004
-
$3.96B(+45.3%)
$13.34B(+4.7%)
Dec 2003
$12.74B(+12.3%)
$2.73B(-18.6%)
$12.74B(+2.6%)
Sep 2003
-
$3.35B(+1.2%)
$12.42B(+3.3%)
Jun 2003
-
$3.31B(-1.4%)
$12.02B(+3.0%)
Mar 2003
-
$3.36B(+39.7%)
$11.67B(+2.9%)
Dec 2002
$11.34B(+19.5%)
$2.40B(-18.6%)
$11.34B(+4.7%)
Sep 2002
-
$2.95B(-0.3%)
$10.83B(+4.4%)
Jun 2002
-
$2.96B(-2.1%)
$10.38B(+3.9%)
Mar 2002
-
$3.02B(+59.7%)
$9.98B(+5.2%)
Dec 2001
$9.49B(+15.6%)
$1.89B(-24.1%)
$9.49B(+4.1%)
Sep 2001
-
$2.50B(-2.8%)
$9.11B(+4.0%)
Jun 2001
-
$2.57B(+1.5%)
$8.77B(+3.5%)
Mar 2001
-
$2.53B(+66.7%)
$8.46B(+3.3%)
Dec 2000
$8.21B(+9.5%)
$1.52B(-29.3%)
$8.20B(+0.8%)
Sep 2000
-
$2.15B(-5.3%)
$8.13B(+2.5%)
Jun 2000
-
$2.27B(+0.2%)
$7.94B(+3.6%)
Mar 2000
-
$2.26B(+55.4%)
$7.66B(+2.3%)
Dec 1999
$7.50B(+18.7%)
$1.46B(-25.4%)
$7.50B(+1.3%)
Sep 1999
-
$1.95B(-2.0%)
$7.40B(+5.1%)
Jun 1999
-
$1.99B(-4.9%)
$7.04B(+5.1%)
Mar 1999
-
$2.09B(+54.3%)
$6.70B(+6.1%)
Dec 1998
$6.31B(+11.0%)
$1.36B(-15.0%)
$6.31B(+5.4%)
Sep 1998
-
$1.60B(-3.4%)
$5.99B(+1.8%)
Jun 1998
-
$1.65B(-3.1%)
$5.89B(+1.7%)
Mar 1998
-
$1.71B(+64.7%)
$5.79B(+1.7%)
Dec 1997
$5.69B(+7.1%)
$1.04B(-30.5%)
$5.69B(+0.0%)
Sep 1997
-
$1.49B(-4.1%)
$5.69B(+1.3%)
Jun 1997
-
$1.55B(-3.2%)
$5.62B(+2.4%)
Mar 1997
-
$1.61B(+55.4%)
$5.48B(+3.2%)
Dec 1996
$5.31B(+21.6%)
$1.03B(-27.2%)
$5.31B(+0.7%)
Sep 1996
-
$1.42B(-0.2%)
$5.28B(+6.9%)
Jun 1996
-
$1.42B(-0.8%)
$4.94B(+5.6%)
Mar 1996
-
$1.44B(+43.6%)
$4.68B(+5.8%)
Dec 1995
$4.37B(+23.7%)
$999.00M(-7.6%)
$4.42B(+6.1%)
Sep 1995
-
$1.08B(-7.1%)
$4.17B(+3.6%)
Jun 1995
-
$1.16B(-1.4%)
$4.02B(+6.0%)
Mar 1995
-
$1.18B(+58.6%)
$3.80B(+7.5%)
Dec 1994
$3.53B(+17.3%)
$744.00M(-20.6%)
$3.53B(+4.5%)
Sep 1994
-
$937.00M(0.0%)
$3.38B(+5.9%)
Jun 1994
-
$937.00M(+2.4%)
$3.19B(+3.4%)
Mar 1994
-
$915.00M(+54.6%)
$3.09B(+2.6%)
Dec 1993
$3.01B(+6.1%)
$592.00M(-21.0%)
$3.01B(+2.1%)
Sep 1993
-
$749.00M(-10.1%)
$2.95B(+0.4%)
Jun 1993
-
$833.00M(-0.6%)
$2.94B(+1.4%)
Mar 1993
-
$838.00M(+58.4%)
$2.90B(+2.2%)
Dec 1992
$2.84B(+6.8%)
$529.00M(-28.3%)
$2.84B(+0.1%)
Sep 1992
-
$738.00M(-6.9%)
$2.83B(+3.3%)
Jun 1992
-
$793.00M(+2.1%)
$2.74B(+2.2%)
Mar 1992
-
$777.00M(+48.0%)
$2.68B(+1.0%)
Dec 1991
$2.66B(+7.7%)
$525.00M(-18.9%)
$2.66B(-2.0%)
Sep 1991
-
$647.00M(-12.0%)
$2.71B(+3.1%)
Jun 1991
-
$735.00M(-2.0%)
$2.63B(+1.7%)
Mar 1991
-
$750.00M(+29.8%)
$2.59B(+2.4%)
Dec 1990
$2.47B(+18.8%)
$578.00M(+2.1%)
$2.52B(+6.4%)
Sep 1990
-
$566.00M(-18.2%)
$2.37B(+1.6%)
Jun 1990
-
$692.00M(+0.4%)
$2.34B(-42.1%)
Mar 1990
-
$689.00M(+61.4%)
$4.03B(+2.7%)
Dec 1989
$2.08B(+15.6%)
$427.00M(-19.1%)
$3.93B(-307.1%)
Sep 1989
-
$528.00M(-77.9%)
-$1.90B(+742.7%)
Jun 1989
-
$2.39B(+310.7%)
-$225.00M(-30.8%)
Mar 1989
-
$582.00M(-110.8%)
-$325.00M(-123.1%)
Dec 1988
$1.79B(+14.7%)
-$5.40B(-345.4%)
$1.40B(-30.7%)
Sep 1988
-
$2.20B(-4.0%)
$2.03B(+11.3%)
Jun 1988
-
$2.29B(-0.9%)
$1.82B(+18.2%)
Mar 1988
-
$2.31B(-148.4%)
$1.54B(+27.3%)
Dec 1987
$1.56B(+24.3%)
-$4.77B(-339.6%)
$1.21B(-29.3%)
Sep 1987
-
$1.99B(-0.8%)
$1.71B(+14.1%)
Jun 1987
-
$2.01B(+1.5%)
$1.50B(+22.7%)
Mar 1987
-
$1.98B(-146.4%)
$1.22B(+24.2%)
Dec 1986
$1.26B(+15.4%)
-$4.27B(-339.8%)
$983.60M(-26.2%)
Sep 1986
-
$1.78B(+2.9%)
$1.33B(+15.6%)
Jun 1986
-
$1.73B(-0.6%)
$1.15B(+16.0%)
Mar 1986
-
$1.74B(-144.4%)
$994.50M(+18.4%)
Dec 1985
$1.09B(+12.2%)
-$3.92B(-344.8%)
$840.00M(-10.4%)
Sep 1985
-
$1.60B(+1.9%)
$937.00M(+12.0%)
Jun 1985
-
$1.57B(-1.0%)
$836.60M(+3.2%)
Mar 1985
-
$1.59B(-141.5%)
$811.00M(+8.8%)
Dec 1984
$971.80M
-$3.83B(-354.7%)
$745.50M(-83.7%)
Sep 1984
-
$1.50B(-2.9%)
$4.57B(+48.9%)
Jun 1984
-
$1.55B(+1.6%)
$3.07B(+101.6%)
Mar 1984
-
$1.52B
$1.52B

FAQ

  • What is Johnson & Johnson annual EBITDA?
  • What is the all time high annual EBITDA for Johnson & Johnson?
  • What is Johnson & Johnson annual EBITDA year-on-year change?
  • What is Johnson & Johnson quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Johnson & Johnson?
  • What is Johnson & Johnson quarterly EBITDA year-on-year change?
  • What is Johnson & Johnson TTM EBITDA?
  • What is the all time high TTM EBITDA for Johnson & Johnson?
  • What is Johnson & Johnson TTM EBITDA year-on-year change?

What is Johnson & Johnson annual EBITDA?

The current annual EBITDA of JNJ is $21.25B

What is the all time high annual EBITDA for Johnson & Johnson?

Johnson & Johnson all-time high annual EBITDA is $26.75B

What is Johnson & Johnson annual EBITDA year-on-year change?

Over the past year, JNJ annual EBITDA has changed by -$2.07B (-8.88%)

What is Johnson & Johnson quarterly EBITDA?

The current quarterly EBITDA of JNJ is $3.64B

What is the all time high quarterly EBITDA for Johnson & Johnson?

Johnson & Johnson all-time high quarterly EBITDA is $9.39B

What is Johnson & Johnson quarterly EBITDA year-on-year change?

Over the past year, JNJ quarterly EBITDA has changed by -$1.74B (-32.29%)

What is Johnson & Johnson TTM EBITDA?

The current TTM EBITDA of JNJ is $22.50B

What is the all time high TTM EBITDA for Johnson & Johnson?

Johnson & Johnson all-time high TTM EBITDA is $28.20B

What is Johnson & Johnson TTM EBITDA year-on-year change?

Over the past year, JNJ TTM EBITDA has changed by -$3.18B (-12.38%)
On this page